GSK3B and persistent truncus arteriosus: The results showed that FoxO1 and glycogen synthase kinase‐3 beta (GSK3β) phosphorylation were significantly increased in TAC model as compared with Sham group, Ext.R treatment significantly decreased FoxO1 and GSK3β phosphorylation (Figure S4, Supporting Information).